The selection of fluid for resuscitation should be based on a comprehensive evaluation of the patient's volume status, electrolyte levels, the underlying cause of hypovolemia, comorbidities, and numerous other factors
Rucker, Ph.D
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Mitochondrial NADH kinase converts NADH to NADPH, consuming one ATP molecule in the process
Sofwave does not require any recovery because it does not use any needles or incisions
You will require maintenance sessions every 6 months to a year